Emisphere Technologies And Alchemia To Research An Oral Formulation Of Fondaparinux With Eligen(R) Technology
Links shared publicly online about this topic.
- 1,299total visits
Emisphere Technologies And Alchemia To Research An Oral Formulation Of Fondaparinux With Eligen(R) Technology
Emisphere Technologies, Inc. (OTCBB:EMIS) and Alchemia Ltd. (ASX:ACL) announced that they are joining efforts to develop an oral formulation of the anti-coagulant drug fondaparinux with Emisphere'
View full resource at medicalnewstoday.com
Tags: Drug
Most Recently Shared on March 21, 2010 at 12:17 pm By:
Emisphere Technologies And Alchemia To Research An Oral Formulation Of Fondaparinux With Eligen(R) Technology http://ow.ly/16R5rF
Advertisement
